- United States
- /
- Medical Equipment
- /
- NasdaqCM:NXL
Nexalin Technology Second Quarter 2024 Earnings: US$0.17 loss per share (vs US$0.11 loss in 2Q 2023)
Nexalin Technology (NASDAQ:NXL) Second Quarter 2024 Results
Key Financial Results
- Revenue: US$26.8k (down 25% from 2Q 2023).
- Net loss: US$1.28m (loss widened by 56% from 2Q 2023).
- US$0.17 loss per share (further deteriorated from US$0.11 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Nexalin Technology shares are down 13% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Nexalin Technology (2 are a bit unpleasant) you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Nexalin Technology might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:NXL
Nexalin Technology
A medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China.
Medium-low risk with adequate balance sheet.
Market Insights
Weekly Picks

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fiducian: Compliance Clouds or Value Opportunity?
Willamette Valley Vineyards (WVVI): Not-So-Great Value
Recently Updated Narratives

ADNOC Gas future shines with a 21.4% revenue surge
Watch Pulse Seismic Outperform with 13.6% Revenue Growth in the Coming Years
Significantly undervalued gold explorer in Timmins, finally getting traction
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
